MF
McNamara Financial Services, Inc.
13F filer · CIK 0001622431Reported Jul 22, 2026
Net buyer this quarter
13F portfolio value$580MU.S. long equity reported on 13F
Positions343 new · 1 closed
Net flow last quarter+$1.44MBuys minus sells
Top 10 positions weight6.7%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 22, 202634 positions | |||||
| PBPMBSPuramed Bioscience Inc. | $22.8M | 3.93% | 0.23% | +3.9% | Q4 2025 |
| $3.72M | 0.64% | Not reported | -0.6% | Q4 2017 | |
| $2.6M | 0.45% | Not reported | -1.2% | Q1 2016 | |
| $2.59M | 0.45% | 0.00% | -3.3% | Q3 2024 | |
| $1.89M | 0.33% | 0.00% | +7.5% | Q2 2020 | |
| $1.2M | 0.21% | 0.00% | Not reported | Q1 2020 | |
| $1.18M | 0.20% | 0.00% | Not reported | Q2 2025 | |
| $958K | 0.17% | Not reported | -3.8% | Q1 2016 | |
| $948K | 0.16% | 0.00% | Not reported | Q2 2025 | |
| $767K | 0.13% | 0.00% | +0.8% | Q1 2016 | |
| $747K | 0.13% | 0.00% | Not reported | Q3 2024 | |
| $732K | 0.13% | 0.00% | Not reported | Q1 2024 | |
| $718K | 0.12% | 0.00% | Not reported | Q3 2024 | |
| $659K | 0.11% | 0.00% | Not reported | Q1 2024 | |
| $596K | 0.10% | Not reported | +0.1% | Q1 2026 | |
| $559K | 0.10% | 0.00% | +0.5% | Q4 2022 | |
| $520K | 0.09% | 0.00% | Not reported | Q4 2025 | |
| $495K | 0.09% | 0.00% | Not reported | Q1 2023 | |
| $473K | 0.08% | 0.00% | -6.5% | Q1 2025 | |
| $465K | 0.08% | 0.00% | Not reported | Q3 2024 | |
| $464K | 0.08% | 0.00% | -2.6% | Q3 2024 | |
| $460K | 0.08% | 0.00% | Not reported | Q4 2019 | |
| $447K | 0.08% | 0.00% | Not reported | Q1 2016 | |
| $419K | 0.07% | 0.00% | Not reported | Q1 2025 | |
| $418K | 0.07% | Not reported | Not reported | Q3 2025 | |
| $402K | 0.07% | 0.00% | Not reported | Q3 2024 | |
| $345K | 0.06% | 0.00% | Not reported | Q2 2023 | |
| $334K | 0.06% | 0.00% | Not reported | Q4 2024 | |
| $326K | 0.06% | 0.00% | Not reported | Q3 2024 | |
| $280K | 0.05% | 0.00% | New | Q2 2026 | |
| $236K | 0.04% | 0.00% | Not reported | Q3 2024 | |
| $236K | 0.04% | 0.03% | +1.0% | Q1 2016 | |
| $220K | 0.04% | 0.00% | New | Q2 2026 | |
| $9.29K | 0.00% | 0.03% | Not reported | Q3 2022 | |
| Q1 2026Reported Apr 9, 202632 positions | |||||
| PBPMBSPuramed Bioscience Inc. | $22M | 4.17% | 0.22% | +2.1% | Q4 2025 |
| $3.75M | 0.71% | Not reported | +7.0% | Q4 2017 | |
| $2.47M | 0.47% | Not reported | -0.6% | Q1 2016 | |
| $2.34M | 0.44% | 0.00% | -10.8% | Q3 2024 | |
| $1.54M | 0.29% | 0.00% | 0.0% | Q2 2020 | |
| $1.38M | 0.26% | 0.00% | Not reported | Q1 2020 | |
| $945K | 0.18% | 0.00% | -1.4% | Q1 2016 | |
| $896K | 0.17% | 0.00% | -4.8% | Q2 2025 | |
| $837K | 0.16% | Not reported | -0.2% | Q1 2016 | |
| $704K | 0.13% | 0.00% | Not reported | Q2 2025 | |
| $645K | 0.12% | 0.00% | -1.0% | Q3 2024 | |
| $633K | 0.12% | 0.00% | Not reported | Q3 2024 | |
| $600K | 0.11% | 0.00% | Not reported | Q1 2024 | |
| $576K | 0.11% | 0.00% | Not reported | Q1 2024 | |
| $535K | 0.10% | 0.00% | Not reported | Q4 2022 | |
| $518K | 0.10% | Not reported | New | Q1 2026 | |
| $491K | 0.09% | 0.00% | +74.8% | Q1 2023 | |
| $440K | 0.08% | 0.00% | Not reported | Q1 2016 | |
| $405K | 0.08% | 0.00% | Not reported | Q1 2025 | |
| $389K | 0.07% | 0.00% | Not reported | Q3 2024 | |
| $340K | 0.06% | Not reported | +11.0% | Q3 2025 | |
| $313K | 0.06% | 0.00% | Not reported | Q3 2024 | |
| $310K | 0.06% | 0.00% | -11.5% | Q3 2024 | |
| $282K | 0.05% | 0.00% | Not reported | Q4 2019 | |
| $279K | 0.05% | 0.00% | Not reported | Q3 2024 | |
| $277K | 0.05% | 0.00% | Not reported | Q1 2025 | |
| $263K | 0.05% | 0.00% | Not reported | Q4 2024 | |
| $256K | 0.05% | 0.00% | Not reported | Q4 2025 | |
| $238K | 0.05% | 0.00% | Not reported | Q1 2025 | |
| $235K | 0.04% | 0.03% | +6.2% | Q1 2016 | |
| $220K | 0.04% | 0.00% | Not reported | Q3 2024 | |
| $7.07K | 0.00% | 0.03% | Not reported | Q3 2022 | |
| Q4 2025Reported Jan 21, 202633 positions | |||||
| PBPMBSPuramed Bioscience Inc. | $21.6M | 4.10% | 0.22% | New | Q4 2025 |
| $3.53M | 0.67% | Not reported | -90.3% | Q4 2017 | |
| $2.8M | 0.53% | 0.00% | Not reported | Q3 2024 | |
| $2.4M | 0.46% | Not reported | -2.6% | Q1 2016 | |
| $1.65M | 0.31% | 0.00% | +0.9% | Q2 2020 | |
| $1.28M | 0.24% | 0.00% | Not reported | Q1 2020 | |
| $1.02M | 0.19% | 0.00% | -1.5% | Q2 2025 | |
| $910K | 0.17% | Not reported | -1.1% | Q1 2016 | |
| $713K | 0.14% | 0.00% | +1.5% | Q3 2024 | |
| $680K | 0.13% | 0.00% | Not reported | Q1 2016 | |
| $671K | 0.13% | 0.00% | -17.5% | Q1 2024 | |
| $638K | 0.12% | 0.00% | Not reported | Q1 2024 | |
| $592K | 0.11% | 0.00% | Not reported | Q3 2024 | |
| $527K | 0.10% | 0.00% | -1.1% | Q2 2025 | |
| $453K | 0.09% | 0.00% | -3.3% | Q4 2022 | |
| $436K | 0.08% | 0.00% | Not reported | Q1 2016 | |
| $404K | 0.08% | 0.00% | Not reported | Q3 2024 | |
| $367K | 0.07% | 0.00% | +3.4% | Q1 2023 | |
| $345K | 0.07% | 0.00% | Not reported | Q1 2025 | |
| $335K | 0.06% | Not reported | Not reported | Q3 2025 | |
| $315K | 0.06% | 0.00% | Not reported | Q3 2024 | |
| $315K | 0.06% | 0.00% | Not reported | Q3 2024 | |
| $313K | 0.06% | 0.00% | Not reported | Q3 2024 | |
| $289K | 0.05% | 0.00% | Not reported | Q2 2023 | |
| $284K | 0.05% | 0.00% | Not reported | Q4 2024 | |
| $275K | 0.05% | 0.00% | +1.9% | Q1 2025 | |
| $222K | 0.04% | 0.03% | +1.2% | Q1 2016 | |
| $205K | 0.04% | 0.00% | New | Q4 2025 | |
| $204K | 0.04% | 0.00% | -0.2% | Q1 2025 | |
| $204K | 0.04% | 0.00% | Not reported | Q3 2024 | |
| $202K | 0.04% | 0.00% | New | Q4 2025 | |
| $200K | 0.04% | 0.00% | New | Q4 2025 | |
| $12.8K | 0.00% | 0.03% | Not reported | Q3 2022 | |
| Q3 2025Reported Nov 14, 202530 positions | |||||
| $36.5M | 6.78% | Not reported | +1.8% | Q4 2017 | |
| $2.8M | 0.52% | 0.00% | Not reported | Q3 2024 | |
| $2.42M | 0.45% | Not reported | -0.6% | Q1 2016 | |
| $1.53M | 0.28% | 0.00% | 0.0% | Q2 2020 | |
| $1.25M | 0.23% | 0.00% | -5.3% | Q1 2020 | |
| $1.01M | 0.19% | 0.00% | Not reported | Q2 2025 | |
| $968K | 0.18% | Not reported | -2.3% | Q1 2016 | |
| $775K | 0.14% | 0.00% | Not reported | Q1 2024 | |
| $688K | 0.13% | 0.00% | Not reported | Q3 2024 | |
| $641K | 0.12% | 0.00% | Not reported | Q3 2024 | |
| $637K | 0.12% | 0.00% | Not reported | Q1 2016 | |
| $607K | 0.11% | 0.00% | Not reported | Q1 2024 | |
| $502K | 0.09% | 0.00% | Not reported | Q2 2025 | |
| $468K | 0.09% | 0.00% | Not reported | Q1 2016 | |
| $420K | 0.08% | 0.00% | Not reported | Q4 2022 | |
| $392K | 0.07% | Not reported | Not reported | Q1 2017 | |
| $380K | 0.07% | 0.00% | Not reported | Q1 2023 | |
| $366K | 0.07% | 0.00% | Not reported | Q3 2024 | |
| $332K | 0.06% | 0.00% | -7.1% | Q3 2024 | |
| $322K | 0.06% | 0.00% | Not reported | Q3 2024 | |
| $319K | 0.06% | 0.00% | Not reported | Q2 2023 | |
| $313K | 0.06% | 0.00% | Not reported | Q1 2025 | |
| $295K | 0.05% | 0.00% | Not reported | Q3 2024 | |
| $260K | 0.05% | Not reported | New | Q3 2025 | |
| $254K | 0.05% | 0.00% | Not reported | Q4 2024 | |
| $239K | 0.04% | 0.00% | Not reported | Q1 2025 | |
| $233K | 0.04% | 0.00% | Not reported | Q1 2025 | |
| $220K | 0.04% | 0.03% | +1.1% | Q1 2016 | |
| $206K | 0.04% | 0.00% | Not reported | Q3 2024 | |
| $18.2K | 0.00% | 0.03% | Not reported | Q3 2022 | |
Premium opens every quarter this fund has filed